Penile Rehabilitation Protocols
Post-prostatectomy recovery: PDE5 + VED + injection timing and AUA guidance
Evidence grade 3 of 5, Mixed. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- No FDA-approved 'rehabilitation' protocol; uses approved drugs/devices off a defined regimen
Reference only. Not medical advice.
What can go wrong
The interventions carry their own risks (PDE5 nitrate contraindication; injection priapism/fibrosis; VED bruising). The deeper issue is that rehabilitation is widely practiced on biologically plausible grounds but the highest-quality trials are inconsistent, patients should be counseled that early PDE5-inhibitor use assists on-demand erections during recovery but may not improve eventual spontaneous function.
This is something to take to a clinician. The Atlas can tell you what is known about penile rehabilitation protocols in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Penile rehabilitation is the practice of using ED therapies after radical prostatectomy (or other pelvic treatment) to preserve erectile tissue while the cavernosal nerves recover. Regimens combine PDE5 inhibitors, vacuum erection devices, intracavernosal injection, and sometimes intraurethral alprostadil. The rationale is preventing hypoxia-driven fibrosis and length loss. Crucially, the AUA's 2018 guideline found inadequate evidence to recommend any specific regimen, and trials have not clearly shown that early PDE5-inhibitor use restores spontaneous, unassisted erections.
The protocol everyone uses and no trial has definitively validated.
What people take it for
These are the reasons people give for taking it. They are not effects it has been shown to have.
How it is supposed to work
After nerve-sparing prostatectomy, temporary loss of nocturnal/spontaneous erections leaves cavernosal tissue chronically hypoxic, promoting smooth-muscle apoptosis and collagen deposition (fibrosis), which can permanently impair erections. Rehabilitation aims to periodically oxygenate the tissue, via drug-, vacuum-, or injection-induced engorgement, to limit this damage while the cavernosal nerves slowly regenerate over 12-24 months.
The evidence gap
Despite near-universal clinical adoption, randomized trials (including scheduled vs on-demand PDE5 dosing) have not consistently demonstrated that any specific rehabilitation regimen improves recovery of spontaneous, unassisted erections. The AUA panel concluded data are inadequate to favor one protocol over another, so 'rehabilitation' is a reasonable, individualized strategy rather than a proven, standardized cure.
Safety in detail
Penile rehabilitation combines pharmacologic and device/injection therapies after major pelvic surgery and requires individualized planning and monitoring by a qualified urologist; intracavernosal injection in particular carries documented risks of priapism and fibrosis.
What people get wrong
Often saidPenile rehabilitation guarantees you get your erections back
ActuallyNo regimen is proven to restore spontaneous function; the AUA found inadequate evidence to recommend a specific protocol. It is a plausible, individualized strategy, not a guarantee.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
Set against the alternatives
Combination approaches (PDE5 inhibitor plus VED, sometimes plus injection) are common and may outperform monotherapy for maintaining tissue health, but head-to-head superiority data are limited. Injection (Trimix/alprostadil) is the most reliable way to produce an erection early after surgery when nerves are not yet functioning.
At a glance
- Goal
- Preserve erectile tissue during nerve recovery
- Tools
- PDE5 inhibitors, VED, intracavernosal injection, intraurethral alprostadil
- AUA 2018
- Inadequate data to recommend any specific regimen
- Key uncertainty
- Early PDE5i may not improve unassisted erections
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Penile Rehabilitation Protocols. A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- Children and teenagers. We have not checked what is known about younger people.
- Where we land. We have not taken a position on this yet.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
AUA Erectile Dysfunction Guideline (rehabilitation statements)2018
Inadequate data to recommend a specific penile-rehabilitation regimen; early PDE5i may not improve spontaneous unassisted erectile function